APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Cancer Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastrointestinal Cancer Drugs Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchGastrointestinal Cancer Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Cancer Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Cancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Cancer Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Cancer Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gastrointestinal Cancer Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastrointestinal Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal Cancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal Cancer Drugs include Sanofi, Johnson & Johnson Private, Novartis, Roche, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb Company and Celgene Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastrointestinal Cancer Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastrointestinal Cancer Drugs market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastrointestinal Cancer Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastrointestinal Cancer Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastrointestinal Cancer Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastrointestinal Cancer Drugs Market by Company

Sanofi

Johnson & Johnson Private

Novartis

Roche

Eli Lilly and Company

Pfizer

GlaxoSmithKline

Bristol-Myers Squibb Company

Celgene Corporation

Amgen & Amgen Ireland

Gastrointestinal Cancer Drugs Segment by Type

Oncology

Radiology

Others

Gastrointestinal Cancer Drugs Segment by Application

Specialized Cancer Treatment Centers

Clinics

Hospitals

Ambulatory Surgical Centers

Gastrointestinal Cancer Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Cancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Cancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Cancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal Cancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastrointestinal Cancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oncology Table 2. Major Company of Radiology Table 3. Major Company of Others Table 4. Global Gastrointestinal Cancer Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 6. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Gastrointestinal Cancer Drugs Price by Type (2021-2026) & (US$/g) Table 10. Global Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (g) Table 11. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Gastrointestinal Cancer Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Gastrointestinal Cancer Drugs Price by Type (2027-2032) & (US$/g) Table 15. North America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 16. North America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 18. Europe Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 20. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 22. Latin America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (g) Table 24. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Gastrointestinal Cancer Drugs Industry Trends Table 26. Gastrointestinal Cancer Drugs Industry Drivers Table 27. Gastrointestinal Cancer Drugs Industry Opportunities and Challenges Table 28. Gastrointestinal Cancer Drugs Industry Restraints Table 29. Global Gastrointestinal Cancer Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Gastrointestinal Cancer Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Gastrointestinal Cancer Drugs Sales by Company (2021-2026) & (g) Table 32. Global Gastrointestinal Cancer Drugs Sales Share by Company (2021-2026) Table 33. Global Gastrointestinal Cancer Drugs Market Price by Company (2021-2026) & (US$/g) Table 34. Global Gastrointestinal Cancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Gastrointestinal Cancer Drugs Major Company Production Sites and Headquarters Table 36. Global Gastrointestinal Cancer Drugs Company, Product Type & Application Table 37. Global Gastrointestinal Cancer Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Gastrointestinal Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Gastrointestinal Cancer Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Gastrointestinal Cancer Drugs Sales by Region (2021-2026) & (g) Table 42. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Gastrointestinal Cancer Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Gastrointestinal Cancer Drugs Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Global Gastrointestinal Cancer Drugs Sales by Region (2027-2032) & (g) Table 47. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Gastrointestinal Cancer Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Gastrointestinal Cancer Drugs Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 51. Global Gastrointestinal Cancer Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 53. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Gastrointestinal Cancer Drugs Price by Application (2021-2026) & (US$/g) Table 57. Global Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (g) Table 58. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Gastrointestinal Cancer Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Gastrointestinal Cancer Drugs Price by Application (2027-2032) & (US$/g) Table 62. North America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 63. North America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 65. Europe Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 67. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 69. Latin America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (g) Table 71. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. Sanofi Gastrointestinal Cancer Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. Johnson & Johnson Private Company Information Table 78. Johnson & Johnson Private Business Overview Table 79. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Portfolio Table 81. Johnson & Johnson Private Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. Novartis Gastrointestinal Cancer Drugs Product Portfolio Table 86. Novartis Recent Development Table 87. Roche Company Information Table 88. Roche Business Overview Table 89. Roche Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. Roche Gastrointestinal Cancer Drugs Product Portfolio Table 91. Roche Recent Development Table 92. Eli Lilly and Company Company Information Table 93. Eli Lilly and Company Business Overview Table 94. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 95. Eli Lilly and Company Gastrointestinal Cancer Drugs Product Portfolio Table 96. Eli Lilly and Company Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 100. Pfizer Gastrointestinal Cancer Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Gastrointestinal Cancer Drugs Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Bristol-Myers Squibb Company Company Information Table 108. Bristol-Myers Squibb Company Business Overview Table 109. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 110. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Portfolio Table 111. Bristol-Myers Squibb Company Recent Development Table 112. Celgene Corporation Company Information Table 113. Celgene Corporation Business Overview Table 114. Celgene Corporation Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 115. Celgene Corporation Gastrointestinal Cancer Drugs Product Portfolio Table 116. Celgene Corporation Recent Development Table 117. Amgen & Amgen Ireland Company Information Table 118. Amgen & Amgen Ireland Business Overview Table 119. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 120. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Portfolio Table 121. Amgen & Amgen Ireland Recent Development Table 122. North America Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 123. North America Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 124. North America Gastrointestinal Cancer Drugs Sales Market Share by Country (2021-2026) Table 125. North America Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032) & (g) Table 126. North America Gastrointestinal Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. North America Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Gastrointestinal Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Gastrointestinal Cancer Drugs Market Share by Country (2021-2026) Table 130. North America Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Gastrointestinal Cancer Drugs Market Share Forecast by Country (2027-2032) Table 132. Europe Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 133. Europe Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 134. Europe Gastrointestinal Cancer Drugs Sales Market Share by Country (2021-2026) Table 135. Europe Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032) & (g) Table 136. Europe Gastrointestinal Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Gastrointestinal Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Gastrointestinal Cancer Drugs Market Share by Country (2021-2026) Table 140. Europe Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Gastrointestinal Cancer Drugs Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 144. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032) & (g) Table 146. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Gastrointestinal Cancer Drugs Market Share by Country (2021-2026) Table 150. Asia-Pacific Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Gastrointestinal Cancer Drugs Market Share Forecast by Country (2027-2032) Table 152. Latin America Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 153. Latin America Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 154. Latin America Gastrointestinal Cancer Drugs Sales Market Share by Country (2021-2026) Table 155. Latin America Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032) & (g) Table 156. Latin America Gastrointestinal Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Gastrointestinal Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Gastrointestinal Cancer Drugs Market Share by Country (2021-2026) Table 160. Latin America Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Gastrointestinal Cancer Drugs Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (g) Table 164. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032) & (g) Table 166. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Gastrointestinal Cancer Drugs Market Share by Country (2021-2026) Table 170. Middle East and Africa Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Gastrointestinal Cancer Drugs Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Gastrointestinal Cancer Drugs Distributors List Table 175. Gastrointestinal Cancer Drugs Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Gastrointestinal Cancer Drugs Image Figure 2. Global Gastrointestinal Cancer Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Cancer Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal Cancer Drugs Sales (2021-2032) & (g) Figure 5. Oncology Image Figure 6. Global Oncology Sales YoY Growth (2021-2032) & (g) Figure 7. Radiology Image Figure 8. Global Radiology Sales YoY Growth (2021-2032) & (g) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (g) Figure 11. Global Gastrointestinal Cancer Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Gastrointestinal Cancer Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Gastrointestinal Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Gastrointestinal Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Gastrointestinal Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Gastrointestinal Cancer Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Specialized Cancer Treatment Centers Image Figure 26. Global Specialized Cancer Treatment Centers Sales YoY Growth (2021-2032) & (g) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (g) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (g) Figure 31. Ambulatory Surgical Centers Image Figure 32. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (g) Figure 33. Global Gastrointestinal Cancer Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Gastrointestinal Cancer Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Gastrointestinal Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Gastrointestinal Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Gastrointestinal Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Gastrointestinal Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 46. North America Gastrointestinal Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Gastrointestinal Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Gastrointestinal Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gastrointestinal Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 50. Europe Gastrointestinal Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gastrointestinal Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Gastrointestinal Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 54. Asia-Pacific Gastrointestinal Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Gastrointestinal Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gastrointestinal Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 58. Latin America Gastrointestinal Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gastrointestinal Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Gastrointestinal Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 62. Middle East and Africa Gastrointestinal Cancer Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Gastrointestinal Cancer Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gastrointestinal Cancer Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Gastrointestinal Cancer Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oncology
  • Radiology
  • Others
Applications
  • Specialized Cancer Treatment Centers
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Sanofi
  • Johnson & Johnson Private
  • Novartis
  • Roche
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Amgen & Amgen Ireland

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastrointestinal Cancer Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastrointestinal Cancer Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastrointestinal Cancer Drugs Market by Type
  6. 1.3.1 Oncology
  7. 1.3.2 Radiology
  8. 1.3.3 Others
  9. 1.4 Global Gastrointestinal Cancer Drugs Market Size by Type
  10. 1.4.1 Global Gastrointestinal Cancer Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Gastrointestinal Cancer Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Gastrointestinal Cancer Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Gastrointestinal Cancer Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Gastrointestinal Cancer Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Gastrointestinal Cancer Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Gastrointestinal Cancer Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Gastrointestinal Cancer Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastrointestinal Cancer Drugs Industry Trends
  2. 2.2 Gastrointestinal Cancer Drugs Industry Drivers
  3. 2.3 Gastrointestinal Cancer Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Cancer Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastrointestinal Cancer Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastrointestinal Cancer Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Gastrointestinal Cancer Drugs Price (2021-2026)
  4. 3.4 Global Gastrointestinal Cancer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastrointestinal Cancer Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Gastrointestinal Cancer Drugs Company, Product Type & Application
  7. 3.7 Global Gastrointestinal Cancer Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastrointestinal Cancer Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastrointestinal Cancer Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastrointestinal Cancer Drugs Tier 1, Tier 2, and Tier 3
4 Gastrointestinal Cancer Drugs Regional Status and Outlook
  1. 4.1 Global Gastrointestinal Cancer Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastrointestinal Cancer Drugs Historic Market Size by Region
  3. 4.2.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastrointestinal Cancer Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastrointestinal Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastrointestinal Cancer Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastrointestinal Cancer Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastrointestinal Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastrointestinal Cancer Drugs by Application
  1. 5.1 Gastrointestinal Cancer Drugs Market by Application
  2. 5.1.1 Specialized Cancer Treatment Centers
  3. 5.1.2 Clinics
  4. 5.1.3 Hospitals
  5. 5.1.4 Ambulatory Surgical Centers
  6. 5.2 Global Gastrointestinal Cancer Drugs Market Size by Application
  7. 5.2.1 Global Gastrointestinal Cancer Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Gastrointestinal Cancer Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Gastrointestinal Cancer Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Gastrointestinal Cancer Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Gastrointestinal Cancer Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Gastrointestinal Cancer Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Gastrointestinal Cancer Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Gastrointestinal Cancer Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Gastrointestinal Cancer Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson Private
  8. 6.2.1 Johnson & Johnson Private Company Information
  9. 6.2.2 Johnson & Johnson Private Business Overview
  10. 6.2.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Portfolio
  12. 6.2.5 Johnson & Johnson Private Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Gastrointestinal Cancer Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Gastrointestinal Cancer Drugs Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Eli Lilly and Company
  26. 6.5.1 Eli Lilly and Company Company Information
  27. 6.5.2 Eli Lilly and Company Business Overview
  28. 6.5.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Product Portfolio
  30. 6.5.5 Eli Lilly and Company Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Gastrointestinal Cancer Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bristol-Myers Squibb Company
  44. 6.8.1 Bristol-Myers Squibb Company Company Information
  45. 6.8.2 Bristol-Myers Squibb Company Business Overview
  46. 6.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Company Recent Developments
  49. 6.9 Celgene Corporation
  50. 6.9.1 Celgene Corporation Company Information
  51. 6.9.2 Celgene Corporation Business Overview
  52. 6.9.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Celgene Corporation Gastrointestinal Cancer Drugs Product Portfolio
  54. 6.9.5 Celgene Corporation Recent Developments
  55. 6.10 Amgen & Amgen Ireland
  56. 6.10.1 Amgen & Amgen Ireland Company Information
  57. 6.10.2 Amgen & Amgen Ireland Business Overview
  58. 6.10.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Portfolio
  60. 6.10.5 Amgen & Amgen Ireland Recent Developments
7 North America by Country
  1. 7.1 North America Gastrointestinal Cancer Drugs Sales by Country
  2. 7.1.1 North America Gastrointestinal Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastrointestinal Cancer Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastrointestinal Cancer Drugs Market Size by Country
  6. 7.2.1 North America Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastrointestinal Cancer Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastrointestinal Cancer Drugs Sales by Country
  2. 8.1.1 Europe Gastrointestinal Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastrointestinal Cancer Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastrointestinal Cancer Drugs Market Size by Country
  6. 8.2.1 Europe Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastrointestinal Cancer Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastrointestinal Cancer Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastrointestinal Cancer Drugs Sales by Country
  2. 10.1.1 South America Gastrointestinal Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastrointestinal Cancer Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastrointestinal Cancer Drugs Market Size by Country
  6. 10.2.1 South America Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastrointestinal Cancer Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastrointestinal Cancer Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Gastrointestinal Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastrointestinal Cancer Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastrointestinal Cancer Drugs Value Chain Analysis
  2. 12.1.1 Gastrointestinal Cancer Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastrointestinal Cancer Drugs Production Mode & Process
  7. 12.2 Gastrointestinal Cancer Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastrointestinal Cancer Drugs Distributors
  10. 12.2.3 Gastrointestinal Cancer Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst